UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABL

International journal of cancer, 2008-06, Vol.122 (12), p.2744-2752

2008

Volltextzugriff (PDF)

p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia

Haematologica (Roma), 2012-02, Vol.97 (2), p.251-257

2012

Volltextzugriff (PDF)

p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia

Haematologica (Roma), 2012-02, Vol.97 (2), p.251-257

2012

Volltextzugriff (PDF)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

BMC cancer, 2012-09, Vol.12 (1), p.411-411, Article 411

2012

Volltextzugriff (PDF)

Targeting the Tetramerization by a Specific Peptide Abrogates the Transformation Potential of BCR/ABL and Some of Its Imatinib-Resistant Mutants

Blood, 2006-11, Vol.108 (11), p.2186-2186

2006

Volltextzugriff (PDF)

CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells

Blood, 2018-01, Vol.131 (3), p.311-322

2018

Volltextzugriff (PDF)

Editorial

Journal of King Saud University. Science, 2016-07, Vol.28 (3), p.203-204

Mian, Afsar

2016

Volltextzugriff (PDF)

Lyophilization Based Isolation of Exosomes

International journal of molecular sciences, 2023-06, Vol.24 (13), p.10477

2023

Volltextzugriff (PDF)

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

BMC cancer, 2021-06, Vol.21 (1), p.713-713, Article 713

2021

Volltextzugriff (PDF)

PB2485: INVESTIGATING THE EXPRESSION OF MUCIN‐1 (MUC‐1) DURING ERYTHROID DIFFERENTIATION

HemaSphere, 2023-08, Vol.7 (S3), p.e5429505-n/a

2023

Volltextzugriff (PDF)

Arsenic Trioxide Suppresses Growth of BCR-ABL1 Positive Cells with “Gatekeeper” or Compound Mutation

Blood, 2021-11, Vol.138 (Supplement 1), p.4346-4346

2021

Volltextzugriff (PDF)

Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway

Neoplasia (New York, N.Y.), 2021-09, Vol.23 (9), p.1016-1027

2021

Volltextzugriff (PDF)

The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia

PLoS genetics, 2015-04, Vol.11 (4), p.e1005144-e1005144

2015

Volltextzugriff (PDF)

PB1837: ANTIBIOTICS; A POSSIBLE ALTERNATE TREATMENT OPTION FOR MYELOID LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e1313111-n/a

2023

Volltextzugriff (PDF)

PB2478: ASCIMINIB INDUCES ERYTHROPOIESIS IN CHRONIC MYELOID LEUKEMIA CELLS THROUGH DIFFERENTIATION AND NOT BY SELECTION

HemaSphere, 2023-08, Vol.7 (S3), p.e853220a-n/a

2023

Volltextzugriff (PDF)

Activation of AKT/mTOR Pathway in Ph+ Acute Lymphoblastic Leukemia (ALL) Leads to Non-Mutational Resistance

Blood, 2019-11, Vol.134 (Supplement_1), p.2570-2570

2019

Volltextzugriff (PDF)

The “Gatekeeper” Mutation T315I in BCR/ABL Confers Additional Oncogenic Activities to Philadelphia Chromosome Positive Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.5196-5196

2019

Volltextzugriff (PDF)

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K

Annals of hematology, 2021-08, Vol.100 (8), p.2023-2029

2021

Volltextzugriff (PDF)

Abstract 4746: Amelioration of hemoglobinopathies by targeted deletion of zinc finger domain within BCL11A gene using CRISPR-Cas9 technology

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4746-4746

2023

Volltextzugriff (PDF)

P1460: INDUCTION OF FETAL HEMOGLOBIN BY TARGETED DELETION OF ZINC FINGER DOMAIN WITHIN BCL11A GENE USING CRISPR‐CAS9 TECHNOLOGY

HemaSphere, 2023-08, Vol.7 (S3), p.e724769c-n/a

2023

Volltextzugriff (PDF)

PB1712: LYOPHILIZATION BASED ISOLATION OF EXOSOMES FOR DELIVERY OF DRUGS AND PROTEIN

HemaSphere, 2023-08, Vol.7 (S3), p.e9223348-n/a

2023

Volltextzugriff (PDF)

Subtractive Interaction Proteomics Reveal a Network of Signaling Pathways Activated By an Oncogenic Transcription Factor in High Risk AML

Blood, 2018-11, Vol.132 (Supplement 1), p.3917-3917

2018

Volltextzugriff (PDF)

Metallic nanoscale-knife application in cancer theranostics

Smart materials in medicine, 2023, Vol.4, p.313-336

2023

Volltextzugriff (PDF)

Deterioration Impact of Indian Crested Porcupine Hystrix indica on Irrigated Forest Plantations in Punjab Pakistan

Pakistan journal of zoology, 2014-12, Vol.46 (6)

2014

Volltextzugriff (PDF)

Abstract 833: Exosomes isolation via lyophilization for Philadelphia-positive leukemia therapy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.833-833

2023

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABL

p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia

p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I

Targeting the Tetramerization by a Specific Peptide Abrogates the Transformation Potential of BCR/ABL and Some of Its Imatinib-Resistant Mutants

CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells

Editorial

Lyophilization Based Isolation of Exosomes

AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia

PB2485: INVESTIGATING THE EXPRESSION OF MUCIN‐1 (MUC‐1) DURING ERYTHROID DIFFERENTIATION

Arsenic Trioxide Suppresses Growth of BCR-ABL1 Positive Cells with “Gatekeeper” or Compound Mutation

Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway

The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia chromosome-positive acute lymphatic leukemia

PB1837: ANTIBIOTICS; A POSSIBLE ALTERNATE TREATMENT OPTION FOR MYELOID LEUKEMIA

PB2478: ASCIMINIB INDUCES ERYTHROPOIESIS IN CHRONIC MYELOID LEUKEMIA CELLS THROUGH DIFFERENTIATION AND NOT BY SELECTION

Activation of AKT/mTOR Pathway in Ph+ Acute Lymphoblastic Leukemia (ALL) Leads to Non-Mutational Resistance

The “Gatekeeper” Mutation T315I in BCR/ABL Confers Additional Oncogenic Activities to Philadelphia Chromosome Positive Leukemia

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K

Abstract 4746: Amelioration of hemoglobinopathies by targeted deletion of zinc finger domain within BCL11A gene using CRISPR-Cas9 technology

P1460: INDUCTION OF FETAL HEMOGLOBIN BY TARGETED DELETION OF ZINC FINGER DOMAIN WITHIN BCL11A GENE USING CRISPR‐CAS9 TECHNOLOGY

PB1712: LYOPHILIZATION BASED ISOLATION OF EXOSOMES FOR DELIVERY OF DRUGS AND PROTEIN

Subtractive Interaction Proteomics Reveal a Network of Signaling Pathways Activated By an Oncogenic Transcription Factor in High Risk AML

Metallic nanoscale-knife application in cancer theranostics

Deterioration Impact of Indian Crested Porcupine Hystrix indica on Irrigated Forest Plantations in Punjab Pakistan

Abstract 833: Exosomes isolation via lyophilization for Philadelphia-positive leukemia therapy

Suchergebnisse filtern